Boehringer Ingelheim at Festival of Biologics 2026

Oct 13–15, 2026 Basel, Switzerland ~3k attendees Website

Boehringer Ingelheim takes part in 2 sessions at Festival of Biologics 2026 in Basel. Its program centres on developability, the early check of whether a candidate biologic can be manufactured and stay stable. It describes how Boehringer Ingelheim runs that assessment in-house.

OrganizationFestival of Biologics 2026 Attendance
Boehringer Ingelheim
Ingelheim am Rhein, Germany
Chair
Wed Oct 14
11:25
Chair's Remarks
CMC & Developability
Talk
Wed Oct 14
14:10
Developability at Boehringer Ingelheim
How Boehringer Ingelheim uses standard, partly automated early tests to pick biologic drug candidates that will be easy to manufacture.

Explore the full Festival of Biologics 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Basel. Leave your work email and we’ll be in touch.

Privacy

Download the full Festival of Biologics 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Boehringer Ingelheim

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Terrapinn or the Festival of Biologics. Submit a correction